bioAffinity Technologies Hosts CHEST Presentation on CyPath Lung Cancer Risk Assessment
bioAffinity Technologies will sponsor a CHEST 2026 presentation on October 21, 2026, at Phoenix Convention Center. Chief Medical Officer Gordon H. Downie will discuss CyPath Lung’s role in lung cancer risk assessment and pulmonary nodule management. The presentation will include preliminary research on an investigation